Sign in
Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk
Journal article   Peer reviewed

Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk

Eugene R AHN, Gabriella LANDER, Wenche JY, Carlos J BIDOT, Joaquin J JIMENEZ, Lawrence L HORSTMAN and Yeon S AHN
Thrombosis research, Vol.114(2), pp.143-148
2004
PMID: 15306157

Abstract

Cardiology. Vascular system Heart Neurology Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Biological and medical sciences Vascular diseases and vascular malformations of the nervous system Medical sciences Coronary heart disease Blood and lymphatic vessels

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.935 ICAM-1
Web Of Science research areas
Hematology
Peripheral Vascular Disease
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details